Sanjib Bhakta

Sanjib Bhakta

Clarendon Way, LS2 9LU
Leeds, OU, Cameroon

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 87 publications

Editorial: Accelerating antibiotic development from natural products: tackling antimicrobial resistance (AMR).

Editorial: Accelerating antibiotic development from natural products: tackling antimicrobial resistance (AMR).

Journal: Frontiers in antibiotics
Published: June 02, 2026

Advancements in the design and development of pyrazoline-based antimycobacterial agents: an update and future perspectives.

Advancements in the design and development of pyrazoline-based antimycobacterial agents: an update and future perspectives.

Journal: RSC advances
Published: May 28, 2025

Development of Carprofen analogues with activity against Mycobacterium tuberculosis.

Development of Carprofen analogues with activity against Mycobacterium tuberculosis.

Journal: Bioorganic & medicinal chemistry
Published: February 20, 2025

Data transparency and reproducibility in health research: bridging the gap for early-career researchers.

Data transparency and reproducibility in health research: bridging the gap for early-career researchers.

Journal: Frontiers in antibiotics
Published: January 16, 2025

Rapid Gene Silencing Followed by Antimicrobial Susceptibility Testing for Target Validation in Antibiotic Discovery.

Rapid Gene Silencing Followed by Antimicrobial Susceptibility Testing for Target Validation in Antibiotic Discovery.

Journal: Methods in molecular biology (Clifton, N.J.)
Published: July 01, 2024

Modified HT-SPOTi: An Antimicrobial Susceptibility Testing to Evaluate Formulated Therapeutic Combinations Against Bacterial Growth and Viability.

Modified HT-SPOTi: An Antimicrobial Susceptibility Testing to Evaluate Formulated Therapeutic Combinations Against Bacterial Growth and Viability.

Journal: Methods in molecular biology (Clifton, N.J.)
Published: July 01, 2024

Correction: Characterisation of ATP-Dependent Mur Ligases Involved in the Biogenesis of Cell Wall Peptidoglycan in Mycobacterium tuberculosis.

Correction: Characterisation of ATP-Dependent Mur Ligases Involved in the Biogenesis of Cell Wall Peptidoglycan in Mycobacterium tuberculosis.

Journal: PloS one
Published: March 26, 2024

Correction to: Rapid Gene Silencing Followed by Antimicrobial Susceptibility Testing for Target Validation in Antibiotic Discovery.

Correction to: Rapid Gene Silencing Followed by Antimicrobial Susceptibility Testing for Target Validation in Antibiotic Discovery.

Journal: Methods in molecular biology (Clifton, N.J.)
Published: January 01, 2024

Mycobactin analogue interacting with siderophore efflux-pump protein: insights from molecular dynamics simulations and whole-cell assays.

Mycobactin analogue interacting with siderophore efflux-pump protein: insights from molecular dynamics simulations and whole-cell assays.

Journal: Frontiers in antibiotics
Published: December 28, 2023

Rationally Designed Novel Phenyloxazoline Synthase Inhibitors: Chemical Synthesis and Biological Evaluation to Accelerate the Discovery of New Antimycobacterial Antibiotics.

Rationally Designed Novel Phenyloxazoline Synthase Inhibitors: Chemical Synthesis and Biological Evaluation to Accelerate the Discovery of New Antimycobacterial Antibiotics.

Journal: Molecules (Basel, Switzerland)
Published: October 30, 2023

Antimicrobial Peptides Designed against the Ω-Loop of Class A β-Lactamases to Potentiate the Efficacy of β-Lactam Antibiotics.

Antimicrobial Peptides Designed against the Ω-Loop of Class A β-Lactamases to Potentiate the Efficacy of β-Lactam Antibiotics.

Journal: Antibiotics (Basel, Switzerland)
Published: January 27, 2023

C-1 Substituted isoquinolines potentiate the antimycobacterial activity of rifampicin and ethambutol.

C-1 Substituted isoquinolines potentiate the antimycobacterial activity of rifampicin and ethambutol.

Journal: Frontiers in antibiotics
Published: November 10, 2022
Showing 1-12 of 87

Last Updated: 09/26/2026